Literature DB >> 15891494

Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.

Giuseppe Tognini1, Francesco Ferrozzi, Giacomo Garlaschi, Paolo Piazza, Arianna Patti, Raffaele Virdis, Chiara Bertolino, Giancarlo Bertolino, Daniele Manfredini, Maurizio Zompatori, Girolamo Crisi.   

Abstract

OBJECTIVE: The most frequent intracranial appearance in children with neurofibromatosis type 1 (NF1) is represented by the presence of hyperintense lesions on T2-weighted images, the so-called "unidentified bright objects" (UBOs). Di Paolo demonstrated that these lesions represent foci of myelin vacuolization with increased water content. The aim of this study was to investigate the isotropic apparent diffusion coefficient (ADC) values within the UBOs and normal-appearing brain and at the regressed UBO sites.
METHODS: Fifteen consecutive children with NF1 underwent magnetic resonance diffusion evaluation of the brain. Fifteen healthy age- and sex-matched children constituted the control group. Apparent diffusion coefficient maps were obtained, and regions of interest were placed bilaterally in 8 different areas. Two cortical areas were evaluated using single-pixel analysis. Apparent diffusion coefficient values within the UBOs were calculated by using irregular regions of interest. Regressed UBO sites were investigated by using circular regions of interest. Apparent diffusion coefficient values within the different areas were compared using a t test.
RESULTS: Compared with the controls, NF1 patients showed higher ADC values (P < 0.001) in all locations. In the NF1 group, the mean ADC value in the UBOs was higher than in other locations (P < 0.001). The mean ADC value within the regressed UBO sites was higher than in the normal-appearing locations (P < 0.001).
CONCLUSIONS: The higher ADC values in children with NF1 suggest an increase in water content of the normal-appearing brain. The UBOs are the areas with the highest water content. The regressed UBOs sites show higher water content than the normal-appearing areas.

Entities:  

Mesh:

Year:  2005        PMID: 15891494     DOI: 10.1097/01.rct.0000162406.71300.b7

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  15 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

Review 2.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

3.  Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1.

Authors:  Gulhan Ertan; Elcin Zan; David M Yousem; Can Ceritoglu; Aylin Tekes; Andrea Poretti; Thierry A G M Huisman
Journal:  Neuroradiol J       Date:  2014-09-25

4.  Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1.

Authors:  Persefoni N Margariti; Konstantinos Blekas; Frosso G Katzioti; Anastasia K Zikou; Meropi Tzoufi; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 5.315

5.  Magnetic resonance diffusion tensor imaging (MRDTI) of the optic nerve and optic radiations at 3T in children with neurofibromatosis type I (NF-1).

Authors:  Christopher G Filippi; Aaron Bos; Joshua P Nickerson; Michael B Salmela; Chris J Koski; Keith A Cauley
Journal:  Pediatr Radiol       Date:  2011-08-21

6.  Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.

Authors:  José Roberto Lopes Ferraz Filho; Marcos Pontes Munis; Antonio Soares Souza; Rafael Angelo Sanches; Eni Maria Goloni-Bertollo; Erika Cristina Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2008-01-30

7.  Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging.

Authors:  S J P M van Engelen; L C Krab; H A Moll; A de Goede-Bolder; S M F Pluijm; C E Catsman-Berrevoets; Y Elgersma; M H Lequin
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-13       Impact factor: 3.825

8.  Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.

Authors:  Steffie N Tomson; Matthew J Schreiner; Manjari Narayan; Tena Rosser; Nicole Enrique; Alcino J Silva; Genevera I Allen; Susan Y Bookheimer; Carrie E Bearden
Journal:  Hum Brain Mapp       Date:  2015-08-25       Impact factor: 5.038

9.  Evaluation of the basal ganglia in neurofibromatosis type 1.

Authors:  Francesco Nicita; Claudio Di Biasi; Saadi Sollaku; Stefano Cecchini; Vincenzo Salpietro; Angelo Pittalis; Laura Papetti; Fabiana Ursitti; Fiorenza Ulgiati; Anna Maria Zicari; Gian Franco Gualdi; Enrico Properzi; Marzia Duse; Martino Ruggieri; Alberto Spalice
Journal:  Childs Nerv Syst       Date:  2013-07-27       Impact factor: 1.475

10.  Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1.

Authors:  S L Zamboni; T Loenneker; E Boltshauser; E Martin; K A Il'yasov
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.